Mayank Garg, Head of MSAT – mAbs at Biocon Biologics, recently participated in a panel discussion on "Navigating India Pharma Inc's Challenges and Opportunities." He shared insights on “The Relevance and Complexity of Tech Transfer in Biopharma" at the Bengaluru Pharma Summit hosted by Express Pharma. Key Highlights: Tech Transfer in Biopharma: Mayank emphasized the complexities and significance of effective technology transfer to ensure quality and consistency in biopharmaceutical manufacturing. Pharma 4.0: He explored how the integration of cutting-edge digital technologies can revolutionize manufacturing processes, improving accuracy, efficiency, and productivity. Implementation Challenges: Mayank discussed the hurdles in implementing Pharma 4.0, from navigating regulatory frameworks to incorporating new technologies, and provided strategies to surmount these obstacles. We extend our gratitude to Mayank for his valuable contributions and for advancing the dialogue on these vital subjects. For more insights, watch the panel discussion below: https://lnkd.in/gh7KjUyu #BioconBiologics #PharmaSummit #TechTransfer #Pharma4 #BiopharmaInnovation #FutureOfPharma
Biocon Biologics’ Post
More Relevant Posts
-
The landscape in Pharma is changing! Here is how.
Pharma Predictions 2024: 10 Big Changes You Need to Know!
linkedin.com
To view or add a comment, sign in
-
IndustryARC™ updated the market research study on “𝐋𝐢𝐪𝐮𝐢𝐝 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭” 𝐋𝐢𝐪𝐮𝐢𝐝 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 size is forecast to reach US$223.3 billion by 2026, after growing at a CAGR of 5.96% during 2021-2026. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 @ https://lnkd.in/gPvah76D 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐎𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐛𝐲 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: Pharmaceutical companies are increasingly outsourcing their manufacturing processes to contract manufacturers to focus on their core competencies such as research and development, #marketing , and sales. This trend is driven by cost-saving measures, flexibility in production capacity, and access to specialized expertise offered by contract manufacturers. 𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐚𝐧𝐝 𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬: The growing demand for biologics and biosimilars is fueling the expansion of the liquid contract manufacturing market. Biologics, including vaccines, monoclonal #antibodies , and recombinant proteins, require specialized manufacturing processes and expertise. Contract manufacturers equipped with the necessary infrastructure and expertise are well-positioned to capitalize on this trend by offering customized solutions to pharmaceutical and biotechnology companies. ✨ (𝐂𝐫𝐞𝐝𝐢𝐭 𝐂𝐚𝐫𝐝 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐟 𝟏𝟎𝟎𝟎$ 𝐨𝐧 𝐚𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞𝐬 | 𝐔𝐬𝐞 𝐂𝐨𝐝𝐞: 𝐅𝐋𝐀𝐓𝟏𝟎𝟎𝟎 𝐚𝐭 𝐜𝐡𝐞𝐜𝐤𝐨𝐮𝐭) @ https://lnkd.in/gb_fF6fq 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐈𝐧𝐜𝐥𝐮𝐝𝐞 : Lonza | Catalent Pharma Solutions | Thermo Fisher Scientific | AbbVie | Pfizer Centreone Entertainment | Patheon | Evonik | VETTER PHARMA INTERNATIONAL | Boehringer Ingelheim | Recipharm AB | Baxter International Inc. | FAREVA | Almac Group | Jubilant FoodWorks Ltd. | FAMAR| AbbVie | WuXi Biologics | Jubilant FoodWorks Ltd. | Aenova Group #contractmanufacturing #pharmaindustry #biotech #outsourcing #biologics #crops #cmo #pharmasupplychain #drugdevelopment #biopharma #drugmanufacturing #qualitycontrol #regulatorycompliance #innovation #packagingtechnology #healthcaresolutions #supplychainmanagement #manufacturingtrends
To view or add a comment, sign in
-
Here's a brief overview of SARBIOFARM Pvt Ltd: SARBIOFARM Pvt Ltd Profile: CDMO / CRO specializing in custom development and manufacturing of APIs & intermediates. Services: Offers custom synthesis solutions and expertise in new drug discovery. Location: Based in Bangalore, India, a hub for pharmaceutical innovation. Expertise: Known for tailored solutions in the pharmaceutical industry. Team Access: Comprises experienced professionals dedicated to research and innovation. Global Reach: Serving clients worldwide with a focus on quality and efficiency. Partnerships: Collaborates with biotech and pharma companies to bring innovations to market. Vision: Committed to advancing healthcare through cutting-edge research and development. hashtag #CRO hashtag #CDMO hashtag #CRAm hashtag #CustomSynthesis hashtag #Pharma hashtag #Chemicals hashtag #Oncology hashtag #Biosimilars hashtag #MedicinalChemistry hashtag #SarBioFarm hashtag #DrugDiscoveryCRO hashtag #PharmaResearch hashtag #BiotechInnovation hashtag #ScientificBreakthroughs hashtag #ResearchPartnership hashtag #InnovativeMedicine hashtag #BioPharmaCollaboration hashtag #ClinicalResearchOrganization hashtag #DrugDevelopment hashtag #ScientificAdvancemen
To view or add a comment, sign in
-
Here's a brief overview of SARBIOFARM Pvt Ltd: SARBIOFARM Pvt Ltd Profile: CDMO / CRO specializing in custom development and manufacturing of APIs & intermediates. Services: Offers custom synthesis solutions and expertise in new drug discovery. Location: Based in Bangalore, India, a hub for pharmaceutical innovation. Expertise: Known for tailored solutions in the pharmaceutical industry. Team Access: Comprises experienced professionals dedicated to research and innovation. Global Reach: Serving clients worldwide with a focus on quality and efficiency. Partnerships: Collaborates with biotech and pharma companies to bring innovations to market. Vision: Committed to advancing healthcare through cutting-edge research and development. hashtag #CRO hashtag #CDMO hashtag #CRAm hashtag #CustomSynthesis hashtag #Pharma hashtag #Chemicals hashtag #Oncology hashtag #Biosimilars hashtag #MedicinalChemistry hashtag #SarBioFarm hashtag #DrugDiscoveryCRO hashtag #PharmaResearch hashtag #BiotechInnovation hashtag #ScientificBreakthroughs hashtag #ResearchPartnership hashtag #InnovativeMedicine hashtag #BioPharmaCollaboration hashtag #ClinicalResearchOrganization hashtag #DrugDevelopment hashtag #ScientificAdvancemen
To view or add a comment, sign in
-
We have an esteemed line-up of panelists for our end-of-Day 1 panel discussion at the '2nd Aseptic BioPharma Processing Summit' in Vienna on November 9-10th. Moderated by Nigel Cryer FRSC from Bluciela-Lifesciences, who will be joined by Alberto Gonzalez Garrido from Takeda, Klaus Ullherr from Syntegon, and Suzanne Nutter from AstraZeneca. These experts will tackle the topic: ‘’How to Reduce the Risk of Contamination in Drug Manufacturing’’ If you’re interested in Aseptic BioPharma Manufacturing or would like to see the premier list of all the speakers and their topics, please visit: https://lnkd.in/epS-KZN2 and request a brochure now. #paneldiscussion #blucielalifesciences #astrazeneca #takeda #syntegon #innovatrix #asepticprocessing #biopharma #sterilization #cleanairsolutions #fluidpathtechnologies #fluidtransfersolutions #containment #packagingmachines #sterilization #capsulefilling #lyophilization #technology #cleanroomoperations #manufacturing #packaging #sterility #freezedrying #ProcessSolutions #filtration #formulation #FillFinish #advancedtherapies #Vienna #ABPP23
To view or add a comment, sign in
-
𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗙𝗲𝗿𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟬. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The report offers a comprehensive overview of the Biopharmaceutical Fermentation Systems industry chain, encompassing the market status of key players such as Biopharmaceutical Companies and Contract Manufacturing Organizations, focusing on Fermenters and Bioprocess Analyzers. It delves into the development of the industry in both developed and developing markets, examining cutting-edge technology, patents, applications, and market trends. Regionally, North America and Europe exhibit steady growth propelled by government initiatives and heightened consumer awareness, while Asia-Pacific, particularly China, stands out as the global leader with robust domestic demand, supportive policies, and a robust manufacturing base. The report provides a holistic understanding of the Biopharmaceutical Fermentation Systems market, addressing market dynamics, trends, challenges, and opportunities, offering valuable insights into individual components and stakeholders within the industry. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗙𝗲𝗿𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/d4ptWrbH *𝗕𝘆 𝗧𝘆𝗽𝗲: Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture & Media Preparation, Culture Media, Buffers & Inducers, Others *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: GE HealthCare, Thermo Fisher Scientific, Danaher Corporation, Sartorius, Merck Group, Eppendorf , Roche, Lonza, BD #Biopharmaceutical #FermentationSystems #BiopharmaceuticalIndustry #Fermenters #BioprocessAnalyzers #MarketAnalysis #IndustryOverview #TechnologyTrends #ContractManufacturing #NorthAmericaMarket #EuropeMarket #AsiaPacificMarket #ChinaBiopharma #GovernmentInitiatives #ConsumerAwareness #MarketTrends #Innovation #Patents #DomesticDemand #ManufacturingBase #Stakeholders #MarketDynamics #Opportunities #Challenges
To view or add a comment, sign in
-
How the pharma industry can benefit from using modular real-time technology
How the pharma industry can benefit from using modular real-time technology
pharmaceutical-technology.com
To view or add a comment, sign in
-
--The size of global 𝐅𝐢𝐥𝐥 𝐅𝐢𝐧𝐢𝐬𝐡 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 in terms of revenue was estimated to be worth $16.7 billion in 2024 and is poised to reach $25.7 billion by 2029, growing at a CAGR of 8.9% from 2024 to 2029. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 + 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐓𝐎𝐂 𝐚𝐭 https://lnkd.in/dgemMmqc This is mainly due to rise in the use of pre-filled syringes for parenteral dosages, growing demand for vaccines and biologics and increasing pharmaceutical and biotechnology applications. However, high operational costs are predicted to cause market growth barriers. 𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐫𝐞: - Makat Candy Technology GmbH a Syntegon company (Germany) - Syntegon Technology GmbH - IMA s.p.a. (Italy) - BD (US) - West Pharmaceutical Services (US) - Gerresheimer AG (Germany) - Aptar Group Inc. (US) - Datwyler Group (Belgium) - Berry Global, Inc.. (US) - Stevanato Group S.p.A. (Italy) - OPTIMA packaging group (Germany) - Bausch+Ströbel SE + Co. KG (Germany) - groninger & co. gmbh (Germany) - SGD Pharma (France) - SCHOTT Pharma (Germany) - Nipro PharmaPackaging - Nipro Medical Corporation - BAUSCH Advanced Technology Group (US) - MAQUINARIA INDUSTRIAL DARA SL (Spain) Competitors: - Alcami Corporation - AbbVie Contract Manufacturing - Pharmacyclics, an AbbVie Company - AbbVie - Veranova - Dec Group - Intellitech, Inc. - Berkshire Sterile Manufacturing - KP Pharmaceutical Technology Inc. - Catalent Pharma Solutions - Catalent Pharma Solutions Brasil - Pyramid Laboratories (Bhav Nagar) - Cambrex - Argonaut Manufacturing Services Inc. - Abzena - Ajinomoto Bio-Pharma Services - Aldevron - Algorithme Pharma | An Altasciences Company - FUJIFILM Diosynth Biotechnologies - IDT Biologika - INCOG BioPharma Services #𝐅𝐢𝐥𝐥𝐅𝐢𝐧𝐢𝐬𝐡𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 #𝐅𝐢𝐥𝐥𝐅𝐢𝐧𝐢𝐬𝐡𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠Market
To view or add a comment, sign in
-
Here's a brief overview of SARBIOFARM Pvt Ltd: SARBIOFARM Pvt Ltd Profile: CDMO / CRO specializing in custom development and manufacturing of APIs & intermediates. Services: Offers custom synthesis solutions and expertise in new drug discovery. Location: Based in Bangalore, India, a hub for pharmaceutical innovation. Expertise: Known for tailored solutions in the pharmaceutical industry. Team Access: Comprises experienced professionals dedicated to research and innovation. Global Reach: Serving clients worldwide with a focus on quality and efficiency. Partnerships: Collaborates with biotech and pharma companies to bring innovations to market. Vision: Committed to advancing healthcare through cutting-edge research and development. hashtag #CRO hashtag #CDMO hashtag #CRAm hashtag #CustomSynthesis hashtag #Pharma hashtag #Chemicals hashtag #Oncology hashtag #Biosimilars hashtag #MedicinalChemistry hashtag #SarBioFarm hashtag #DrugDiscoveryCRO hashtag #PharmaResearch hashtag #BiotechInnovation hashtag #ScientificBreakthroughs hashtag #ResearchPartnership hashtag #InnovativeMedicine hashtag #BioPharmaCollaboration hashtag #ClinicalResearchOrganization hashtag #DrugDevelopment hashtag #ScientificAdvancemen
To view or add a comment, sign in
-
The 𝐃𝐞𝐩𝐚𝐫𝐭𝐦𝐞𝐧𝐭 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭��𝐜𝐚𝐥𝐬 has launched a new portal to monitor the 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐏𝐨𝐥𝐢𝐜𝐲 𝐨𝐧 𝐑&𝐃 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 in the #Pharma-Medtech sector. The #ICPMR will lead the Drug Discovery Mission, pooling resources from top research institutions. This portal aims to streamline regulatory processes and boost #collaboration between industry and academia. 🌐 🔬 By reducing approval timelines and fostering innovation, India is set to become a #global hub for pharmaceutical and #medtech advancements. 🔗Read More - https://lnkd.in/d-_jXf2F 🖊️Writes - Dr. Jayati Dubey #Pharma #MedTech #Innovation #Research #R&D #Healthcare #TechNews #India
DoP Launches New Portal to Implement R&D Policy in Pharma-Medtech Sector
digitalhealthnews.com
To view or add a comment, sign in
427,832 followers